Cordyceps Sunshine Biotech Dismisses Auditor

Ticker: RAJAF · Form: 6-K · Filed: Mar 19, 2024 · CIK: 1885680

Cordyceps Sunshine Biotech Holdings Co., Ltd. 6-K Filing Summary
FieldDetail
CompanyCordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)
Form Type6-K
Filed DateMar 19, 2024
Risk Levelmedium
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: auditor-change, corporate-governance

TL;DR

Cordyceps Sunshine Biotech just fired its auditor, KCCW Accountancy Corp., on March 18, 2024.

AI Summary

On March 18, 2024, Cordyceps Sunshine Biotech Holdings Co., Ltd. notified KCCW Accountancy Corp. of its decision to dismiss the firm as its independent registered public accounting firm. This change affects the company's financial reporting and audit process.

Why It Matters

The dismissal of an auditor can signal potential issues with financial reporting or internal controls, which could impact investor confidence.

Risk Assessment

Risk Level: medium — Dismissal of an auditor can sometimes precede or indicate underlying financial or governance issues.

Key Players & Entities

  • Cordyceps Sunshine Biotech Holdings Co., Ltd. (company) — The company making the filing and dismissing its auditor.
  • KCCW Accountancy Corp. (company) — The independent registered public accounting firm dismissed by the company.
  • March 18, 2024 (date) — The date the company notified its auditor of the dismissal.

FAQ

What is the effective date of the auditor dismissal?

The company notified KCCW Accountancy Corp. of its decision to dismiss the firm on March 18, 2024.

Who is the auditor being dismissed?

KCCW Accountancy Corp. is the independent registered public accounting firm being dismissed.

What is the name of the company filing this report?

The company filing this report is Cordyceps Sunshine Biotech Holdings Co., Ltd.

What type of filing is this?

This is a Form 6-K, Report of Foreign Private Issuer.

What is the company's principal executive office address?

The company's principal executive office is located at 6th Fl., No. 15, Lane 548, Ruiguang Road, Neihu District, Taipei City, Taiwan.

Filing Stats: 587 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2024-03-19 16:15:37

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: March 18, 2024 CORDYCEPS SUNSHINE BIOTECH HOLDINGS CO., LTD. By: /s/ Szu Hao Huang Name: Szu Hao Huang Title: Director, Chief Executive Officer, Chief Financial Officer 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.